3 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 3 |
| Phase 2 | 1 | Recruiting 1 |
Follow Adcendo ApS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors ADCE-B05 - Solid Tumors (Phase 1) | Phase 1 | Recruiting | Adcendo ApS | 180 | 2026-03-17 | 2026-07-24 |
| First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma Antibody-drug conjugate (ADC) - Metastatic Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma | Phase 1 / Phase 2 | Recruiting | Adcendo ApS | 270 | 2025-06-05 | 2026-09-11 |
| ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours ADCE-T02 - Advanced Solid Tumor, PDAC | Phase 1 | Recruiting | Adcendo ApS | 210 | 2024-11-25 | 2026-09-09 |
Sarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Immunoconjugates (1)
United States (3) · Australia (2) · Belgium (1) · France (1) · Germany (1) · United Kingdom (1)